摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-重氮咪唑-4-甲酰胺 | 102613-59-2

中文名称
5-重氮咪唑-4-甲酰胺
中文别名
——
英文名称
3-diazopyrazole-4-carboxamide
英文别名
(E)-amino-(3-diazoniopyrazol-4-ylidene)methanolate
5-重氮咪唑-4-甲酰胺化学式
CAS
102613-59-2
化学式
C4H3N5O
mdl
——
分子量
137.101
InChiKey
BWICGMXEZWEUJG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.38
  • 重原子数:
    10.0
  • 可旋转键数:
    1.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    98.23
  • 氢给体数:
    1.0
  • 氢受体数:
    3.0

反应信息

  • 作为反应物:
    描述:
    5-重氮咪唑-4-甲酰胺异氰基乙酸乙酯sodium acetate 作用下, 以 丙酮 为溶剂, 以88%的产率得到3,6-Dihydro-4Hpyrazolo[3,4-d][1,2,3]triazin-4-one
    参考文献:
    名称:
    重氮唑与异氰基乙酸乙酯反应的PASE合成1-azolyl-1H-1,2,4-三唑
    摘要:
    通过将5-重氮唑加到异氰基乙酸乙酯中,可实现高达91%的收率的PASE(锅,原子和分步经济)合成1-azolyl-1H-1,2,4-三唑衍生物。
    DOI:
    10.1016/j.mencom.2019.11.016
  • 作为产物:
    描述:
    参考文献:
    名称:
    CHENG C. C.; ELSLAGER E. F.; WERBEL L. M.; PRIEBE S. R.; LEOPOLD W. R., J. MED. CHEM., 29,(1986) N 8, 1544-1547
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Antitumour imidazotetrazines. Part 39. Synthesis of bis(imidazotetrazine)s with saturated spacer groups
    作者:Jill Arrowsmith、Sharon A. Jennings、David A. F. Langnel、Richard T. Wheelhouse、Malcolm F. G. Stevens
    DOI:10.1039/b005652i
    日期:——
    Bis(imidazotetrazine)s (16), related in structure to the antitumour agents mitozolomide (1a) and temozolomide (1b), but linked through the N(3)–N(3′) atoms of the imidazo[5,1-d][1,2,3,5]tetrazine ring-systems, are prepared by interaction of 5-diazoimidazole-4-carboxamide (8) and diisocyanates (15). The presence of the polymethylene linker with/without sulfur and oxygen heteroatoms does not substantially affect the acid stability, base-catalysed decomposition, antitumour activity or DNA base alkylation preference characteristic of the unlinked imidazotetrazines mitozolomide and temozolomide.
    双(咪唑四嗪) (16) 的结构与抗肿瘤药物米唑仑 (1a) 和替莫唑胺 (1b) 相关,但通过咪唑[5,1-d][1,2,3,5]四嗪环系的N(3)–N(3′)原子相连,由5-氮杂咪唑-4-羧酰胺 (8) 和二异氰酸酯 (15) 反应制备而成。含/不含硫和氧杂原子的多亚甲基连接体的存在并未显著影响与未连接的咪唑四嗪米唑仑和替莫唑胺特征相关的酸稳定性、碱催化分解、抗肿瘤活性或DNA碱基烷基化偏好。
  • Pyrazole derivatives. 5. Synthesis and antineoplastic activity of 3-(2-chloroethyl)-3,4-dihydro-4-oxopyrazolo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide and related compounds
    作者:C. C. Cheng、Edward F. Elslager、Leslie M. Werbel、Wilbur R. Leopold
    DOI:10.1021/jm00158a041
    日期:1986.8
    Two pyrazolotetrazine derivatives were synthesized as the analogous prodrugs of the light-sensitive antineoplastic agents dacarbazine and BIC. Both the pyrazole derivatives are stable under ordinary light illumination. Biological evaluation of these pyrazoles revealed that the compound containing a 2-chloroethyl function (6a) demonstrated good antineoplastic activity in experimental animals, but the one containing a methyl function (6b) was inactive. The inactivity of compound 6b may suggest that compound 6a and related imidazotetrazines may simply act as biological alkylating agents per se rather than as prodrugs. The information could also imply that the postulated dealkylation mechanism for the triazene derivatives should be reexamined.
  • Antitumor imidazotetrazines. 14. Synthesis and antitumor activity of 6- and 8-substituted imidazo[5,1-d]-1,2,3,5-tetrazinones and 8-substituted pyrazolo[5,1-d]-1,2,3,5-tetrazinones
    作者:Edward Lunt、Christopher G. Newton、Christopher Smith、Graham P. Stevens、Malcolm F. G. Stevens、Colin G. Straw、Roger J. A. Walsh、Peter J. Warren、Christian Fizames
    DOI:10.1021/jm00385a018
    日期:1987.2
    The systematic variation of the potent antitumor agent mitozolomide (1) is extended to cover alteration of substituents at positions 6 and 8 and to change the imidazo[5,1-d]-1,2,3,5-tetrazinone (1) skeleton to the isomeric pyrazolo-[5,1-d]-1,2,3,5-tetrazinone (17) skeleton. The series of eight 6-alkyl and 6-aralkyl derivatives of 1 showed optimal antitumor activity when the group was small or linear, but activity diminished as size and branching of this substituent increased. This may reflect altered transport characteristics, or failure of the enlarged derivatives to fit a binding site, or possibly a reduced tendency for the derivatives having bulky groups at position 6 to hydrolytically generate the putatively active triazenes (21). Testing of 14 derivatives of 1 differently substituted at position 8 revealed a complex structure-activity relationship, with good antitumor activity obtained for carbamoyl and sulfamoyl groups bearing small substituents. The 8-methylsulfonyl compound had noteworthy activity, but the 8-cyano, 8-nitro, and 8-phenyl derivatives were devoid of useful antitumor activity in these tests. From the limited number of pyrazolotetrazinones (17) reported here, it is suggested that the same conclusions as regards activity also hold true for this ring system.
  • Clark; Deans; Stevens, Journal of Medicinal Chemistry, 1995, vol. 38, # 9, p. 1493 - 1504
    作者:Clark、Deans、Stevens、Tisdale、Wheelhouse、Denny、Hartley
    DOI:——
    日期:——
  • PASE synthesis of 1-azolyl-1H-1,2,4-triazoles by the reaction of diazoazoles with ethyl isocyanoacetate
    作者:Elena V. Sadchikova、Daria L. Alexeeva、Valentine G. Nenajdenko
    DOI:10.1016/j.mencom.2019.11.016
    日期:2019.11
    PASE (pot, atom and step economic) synthesis of 1-azolyl-1H-1,2,4-triazole derivatives in up to 91% yield has been accomplished by addition of 5-diazoazoles to ethyl isocyanoacetate.
    通过将5-重氮唑加到异氰基乙酸乙酯中,可实现高达91%的收率的PASE(锅,原子和分步经济)合成1-azolyl-1H-1,2,4-三唑衍生物。
查看更多